Fundraising Fox
Find your path to Andrew
Sign up to see every warm intro you have to Andrew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Andrew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Andrew Hack is a Partner on the Life Sciences team at Bain Capital, which he joined in 2019. He previously served as Chief Financial Officer of Editas Medicine and as a portfolio manager at Millennium Management running a market-neutral healthcare hedge fund, and earlier worked as a securities analyst at healthcare-focused hedge funds and banks and as Director of Life Sciences at Reify Corporation. He holds an MD and PhD in molecular genetics and cell biology and an AB in biology, all from the University of Chicago.
Invests in
Biotech
Deals · 2
Xilio TherapeuticsBoard seat
via Bain Capital Life Sciences · filed Feb 2021 · $95M raise
JenaValveBoard seat
via Bain Capital Life Sciences · filed Oct 2020 · $66.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Bain Capital Life Sciences
Frequently asked questions
- Who is Andrew Hack?
- Andrew Hack is a Partner on the Life Sciences team at Bain Capital, which he joined in 2019. He previously served as Chief Financial Officer of Editas Medicine and as a portfolio manager at Millennium Management running a market-neutral healthcare hedge fund, and earlier worked as a securities analyst at healthcare-focused hedge funds and banks and as Director of Life Sciences at Reify Corporation. He holds an MD and PhD in molecular genetics and cell biology and an AB in biology, all from the University of Chicago.
- Where does Andrew Hack work?
- Andrew Hack is Partner, Life Sciences at Bain Capital Life Sciences.
- What does Andrew Hack invest in?
- Andrew Hack invests in Biotech.
- What boards does Andrew Hack sit on?
- Andrew Hack holds tracked board seats at Affinivax, Imperative Care Inc, JenaValve, Nuvalent, Xilio Therapeutics.
About this profile. Compiled from public sources — Bain Capital Life Sciences's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights